Premier Health Group CEO Interview: RichTV Live

Premier Health Group

When Rich first profiled Premier Health Group Inc. (CSE:PHGI) (OTCQB:PHGRF), the stock was skyrocketing. After just 30 days, PHGI shares were up an astounding 75%. Since then, they’ve plateaued, but this is a company poised to deliver a lot more value in the future.

Today, Rich interviews the Chief Executive Officer of Premier Health Group, Dr. Essam Hamza. Dr. Hamza completed his MD and Family Practice degree at the University of Alberta in 1999. In 2005, he founded HealthVue and grew the business to include four interconnected high-tech clinics serving over 100,000 patients. He also has extensive capital markets experience.

In this video, Rich and Dr. Hamza discuss PHGI’s recent performance, as well as the company’s short- and long-term goals for the future.

Premier Health Group Provides Sustainable Healthcare Solutions

“The inefficiencies with the Canadian healthcare system are costing us billions of dollars,” Dr. Hamza says.

He goes on to explain that the number of doctors remains stagnant, but the number of patients those doctors treat grows bigger and bigger. This, quite clearly, is not a sustainable model.

PHGI’s solutions make the patients the center of the healthcare model, as opposed to the doctors being at the center. Through telecommunication, patients can quickly and affordably book and visit their doctor. This streamlines the healthcare process and frees doctors up to see more patients.

Enter Your E-mail Address To Subscribe

* indicates required

Premier Health Group’s app—MyHealthAccess—is available on both the Google and Apple stores. Through this, the company already has 80,000 registered users. Any one of those users can book a telemedical appointment 24/7.

Dr. Hamza also discusses his company’s recent acquisition of Livecare. Livecare already services more than 500 health practitioner accounts and has enabled 27,000 telemedicine visits.

“Particularly, their focus was on remote communities and Indigenous communities that are underserved,” he says. “We acquired them not only for their telemedicine platform, but also for their connectivity.”

Premier Health is Already Producing Revenue

“Our run-rate for 2019 was about $11.5 million, and for the end of 2020 we’ve projected about $44 million,” Dr, Hamza adds. “We’ve made a lot of acquisitions recently, and that provides a lot of established revenue. But they’re also all synergistic things, which is important.”

The company’s portfolio has been strategically assembled to give Premier Health Group an edge in delivering telemedicine. The technology involved with virtual care goes beyond telecommunication, as it also involves secure file transfers, virtual diagnostics, and prescription delivery.

To accomplish this, PHGI is partnering with Canadian clinics to both deliver medicine and to help educate patients.

Dr. Hamza also notes that Amazon (NASDAQ:AMZN) has entered the telemedical space. This will help the public become more aware of telemedicine, thus raising PHGI’s profile.

Finally, Dr. Hamza explains that about 40% of the company is under insider ownership. Rich agrees Premier Health Group has a tight float.

Expect to hear more about this remarkable company, as the telemedicine space is developing rapidly. PHGI is the only publicly-traded company in Canada working in telemedicine, allowing patients to also become investors.

For more of RichTV Live’s CEO interviews, check out this video with Halo Labs (OCTQX:AGEEF) CEO Kiran Sidhu or this video with Else Nutrition (TSXV:BABY) (OTCPK:BABYF) CEO Hamutal Yitzhak.

Featured image: DepositPhotos © everythingposs

Please See Disclaimer

If You Liked This Article Click To Share


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Premier Health Group Inc. Bitrics Markets Group Inc. and/or Iman Consulting Group has or expects to receive $800 Canadian dollars from Market Jar Media Inc. for the creation and distribution of the video.

3) Statements and opinions expressed are the opinions of the author and not Bitrics Markets Group Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Bitrics Markets Group Inc. for this Article. Bitrics Markets Group Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Bitrics Markets Group Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Bitrics Markets Group Inc. relies upon the authors to accurately provide this information and Bitrics Markets Group Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Bitrics Markets Group Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Bitrics Markets Group Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Bitrics Markets Group Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Bitrics Markets Group Inc. and its owners, members, officers, directors, partners and consultants may own shares of the profiled companies, which it may sell at any time, including as soon as it deposits such shares into its trading accounts, during our campaign of the profiled companies stock, after our campaign or at any other time. We also may buy and sell securities in the profiled companies which may cause (a) decline in the price of the profiled companies stock due to our selling activities, (b) increased volatility due to our buying and selling of the profiled companies stock and (c) permit us to make substantial profits while we are profiling each of these companies, yet may result in a diminished value to the stock for investors. for any company mentioned in the Article.